Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival Triamcinolone for Eyelid Retraction in TAO
NCT01599273Phase 4Completed
- Sponsor
- Yonsei University
- Start
- May 2012
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in thyroid associated ophthalmopathy (TAO), sponsored by Yonsei University. Started May 2012; status: completed.
02
Drugs
triamcinolone
03
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT01599273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599273.